NRx Pharmaceuticals (NASDAQ:NRXP) Appoints Michael Abrams as Chief Financial Officer
Press Releases
NRx Pharmaceuticals, Inc.  
November 18, 2024

NRx Pharmaceuticals (NASDAQ:NRXP) Appoints Michael Abrams as Chief Financial Officer

Industry veteran with extensive experience in key areas of focusInterim-CFO Richard Narido to focus on HOPE Therapeutics acquisition opportunities

avatar profile Olean Times Herald

Olean Times Herald


Local & Social